Ulinastatin
CAS No. 80449-31-6
Ulinastatin( Bikunin | Mingin | Miraclid | Trypsin inhibitor UTI | Urinary trypsin inhibitor 1 | Urinastatin )
Catalog No. M24803 CAS No. 80449-31-6
Ulinastatin is a multivalent Kunitz-type serine protease inhibitor with anti-inflammatory properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 25MG | 82 | In Stock |
|
| 50MG | 127 | In Stock |
|
| 100MG | 207 | In Stock |
|
| 200MG | 306 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUlinastatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionUlinastatin is a multivalent Kunitz-type serine protease inhibitor with anti-inflammatory properties.
-
DescriptionUlinastatin is a multivalent Kunitz-type serine protease inhibitor with anti-inflammatory properties.
-
In VitroWestern Blot Analysis Cell Line:Human lung epithelial BEAS-2B cells Concentration:500 U, 2500 U, 5000 U Incubation Time:24 hours Result:Markedly attenuated TLR4 expression and NF-κB activation in LPS-stimulated BEAS-2B cells.
-
In VivoAnimal Model:Male C57BL/6 mice (8-10 weeks old, 18-22 g)Dosage:10000 U/kg Administration:i.v.; twice (1 h before and 6 h after LPS treatment)Result:Significantly protected animals from LPS-induced ALI.
-
SynonymsBikunin | Mingin | Miraclid | Trypsin inhibitor UTI | Urinary trypsin inhibitor 1 | Urinastatin
-
PathwayOthers
-
TargetOther Targets
-
RecptorKunitz-type serine protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80449-31-6
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 10 mg/mL
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakahama H , Kuribayashi K , Sugita M , et al. Cytoprotective effect of ulinastatin, a Kunitz-type protease inhibitor, on hypoxic injury in L2 cells treated with antimycin A via stabilization of lysosomal fragility.[J]. Pulmonary Pharmacology & Therapeutics, 1999, 12(1):1-6.
molnova catalog
related products
-
c(Bua-Cpa-Thi-Val-As...
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm a highly efficient, selective and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.
-
(25S)-12β-Hydroxyspi...
(25S)-12β-Hydroxyspirost-4-en-3-one is a natural compound that can be isolated from Dioscorea chiupasensis.
-
Z-YVAD-FMK
AA-Z-YVAD-FMK is a Irreversible caspase-1 inhibitor.
Cart
sales@molnova.com